The Liver Vascular Biology research group ubicated at Esther Koplowitz Centre at IDIBAPS has led a scientific review that compiles and anal1
A team of experts from the European consortium LIVERSCREEN, led by IDIBAPS and funded by the Horizon 2020 programme (847989) has published the first1
Metabolic fatty liver disease affects almost 30% of the population, and 80% of those who are obese. The disease has no cure, but its progression can1
One in four people have fatty liver; a condition that can be reversed with a healthy lifestyle. The nurse, Marta Cervera, explains 5 recommendations1
The study, in which Hospital Clínic-IDIBAPS researchers have participated, shows that the perception of this stigma is associated with a deterioratio1
IDIBAPS researchers have drafted a molecular map of the most common type of liver cancer, hepatocellular carcinoma, when the origin is fatty liver di1
An article published in the journal Nature suggests that immunotherapy is effective in patients with HCC of viral origin but does not increase surviv1
A study published in the journal Nature Medicine proposes a paradigm shift in the approach to steatohepatitis, the most advanced degree of non-alcoho1
